Status | Study |
Completed |
Study Name: Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma Condition: HIV Burkitt's Lymphoma Date: 2012-01-06 Interventions: Drug: Induction Phase |
Completed |
Study Name: Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma Condition: Burkitt Lymphoma B-ALL Date: 2011-02-02 Interventions: Drug: Chemotherapy-Rituximab combination Short cycles of high-dose and conventional chemotherapy in comb |
Recruiting |
Study Name: Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM) Condition: Lymphoma, Non-Hodgkin Malaria Herpesvirus 4, Human Date: 2010-09-04 |
Not yet recruiting |
Study Name: Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL) Condition: Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia Date: 2010-04-12 Interventions: Biological: humanised monoclonal antibody, veltuzumab |
Active, not recruiting |
Study Name: Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma Condition: Burkitt Lymphoma Diffuse Large B-cell Lymphoma, c-MYC Positive Date: 2010-03-23 Interventions: Drug: EPOCH-R EPOCH-R every 21 |
Completed |
Study Name: Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma Condition: Burkitt's Lymphoma Burkitt'S-like Lymphoma Date: 2008-04-28 Interventions: Drug: Rituximab 375 mg/m2 IV d |
Completed |
Study Name: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma Condition: Lymphoma Date: 2006-10-25 Interventions: Biological: filgrastim given s |
Completed |
Study Name: Rituximab Combined With Chemotherapy in Burkitt`s Lymphoma Condition: Acute Lymphoblastic Leukemia Burkitt's Lymphoma Date: 2006-10-13 Interventions: Drug: RITUXIMAB 375 mg/m2/d day 1 |
Completed |
Study Name: Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia Condition: B-cell Acute Lymphoblastic Leukemia Date: 2006-02-08 Interventions: Drug: forodesine hydrochloride (BCX-1777) |
Completed |
Study Name: Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL Condition: Non-Hodgkin Lymphoma Acute Lymphoblastic Leukemia, Mature B-Cell Date: 2005-09-13 Interventions: Drug: Prednison, Vincristine, Cytarabine, Methotrexate, Etoposide, Cyclophosphamide, Doxorubicin The add |